Tag: Prescription Drugs
Prescriptions Rise for Veterinary Drug for COVID-19 Patients
Increase in demand for ivermectin has been accompanied by a fivefold increase in calls to poison control centers
Some High-Priority Groups More Likely to Stop Taking PrEP
Younger individuals, African American and Latinx, those with substance use disorders more likely to discontinue PrEP
2019 to 2020 Saw Increase in Benzodiazepine Overdose ED Visits
Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths
Liraglutide Reduces Visceral Fat in Overweight, Obese Adults
Liraglutide plus diet and physical activity counseling reduce visceral and ectopic fat in overweight, obese adults at high risk for CVD
Roxadustat Treats Anemia in Non-Dialysis-Dependent CKD
Pooled data show roxadustat versus placebo increases hemoglobin levels with an acceptable profile for cardiovascular safety
Among Persons With HIV, More Finish Short-Course TB Prophylaxis
Treatment completion 90.4 percent for three months of rifapentine-isoniazid versus 50.5 percent for six months of isoniazid
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized
Milrinone, Dobutamine Similarly Effective for Cardiogenic Shock
Incidence of adverse clinical outcomes, including in-hospital death, high in both groups in pragmatic randomized clinical trial
Opioid Tapering Tied to Higher Risk for Overdose, Mental Health Crisis
Rates of overdose, mental health crises increased after dose tapering among patients prescribed stable, long-term, higher-dose opioid therapy
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
Rate of disease-free survival at 24 months higher with pembrolizumab versus placebo following nephrectomy
